Werner helicase expression in human fetal and adult aortas

The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis

Werner syndrome (WS) is an adult onset segmental progeroid syndrome caused by mutations in the WRN gene. The WRN gene encodes a 180 kDa nuclear protein that possesses helicase and exonuclease activities. The absence of WRN protein leads to abnormalities in various DNA metabolic pathways such as DNA repair, replication and telomere maintenance. Individuals with WS generally develop normally until the third decade of life, when premature aging phenotypes and a series of age-related disorders begin to manifest. In Japan, where a founder effect has been described, the frequency of Werner heterozygotes appears to be as high as 1/180 in the general population. Due to the relatively non-specific nature of the symptoms and the lack of awareness of the condition, this disease may be under-diagnosed in other parts of the world. Genetic counseling of WS patients follows the path of other autosomal recessive disorders, with special attention needed for cancer surveillance in relatives. Molecular diagnosis of WS is made by nucleotide sequencing and, in some cases, protein analysis. It is also of potential interest to measure WRN activities in WS patients. More than 50 different disease-causing mutations in the WRN gene have been identified in WS patients from all over the world. All but one of these cases has mutations that result in the premature termination of the protein. Here we describe the clinical, molecular and biochemical characteristics of WS for use by medical professionals in a health care setting. Additional information is available through the International Registry of WS (http://www.wernersyndrome.org).

Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes

In the past several years, remarkable progress has been made in the understanding of the mechanisms of premature aging. These rare, genetic conditions offer valuable insights into the normal aging process and the complex biology of cardiovascular disease. Many of these advances have been made in the most dramatic of these disorders, Hutchinson–Gilford progeria syndrome. Although characterized by features of normal aging such as alopecia, skin wrinkling, and osteoporosis, patients with Hutchinson–Gilford progeria syndrome are affected by accelerated, premature arteriosclerotic disease that leads to heart attacks and strokes at a mean age of 13 years. In this review, we highlight recent advances in the biology of premature aging uncovered in Hutchinson–Gilford progeria syndrome and other accelerated aging syndromes, advances that provide insight into the mechanisms of cardiovascular diseases ranging from atherosclerosis to arrhythmias.

Analysis of Werner's expression within the brain and primary neuronal culture

Werner's syndrome is a genetic progeria disorder caused by mutation of the Werner gene (WRN). The presence of mutations in the WRN gene is believed to result in a deleterious loss of normal WRN function, which has been best characterized for its role as a DNA helicase and exonuclease. The WRN gene is known to be expressed within the central nervous system, with Werner's syndrome associated with several neuropathological abnormalities including brain atrophy, gliosis and extensive cytoskeletal abnormalities. While WRN has been intensely investigated in primary fibroblast and fibroblast cell lines, at present little is known about the normal expression pattern of the WRN protein in the brain or primary neuronal cultures. In the present study we demonstrate that WRN is expressed throughout the brain, and is present in both neurons and glia. Similarly, WRN is present in both primary neurons and glia in cell culture, with extensive immunoreactivity present in the neuritic processes or neurons. Analysis of WRN RNA revealed that WRN was expressed at its highest levels in brain tissue from embryonic tissue, undergoing a biphasic pattern expression from early post-natal period into adulthood. Taken together, these data indicate that WRN is present in the cells of the brain, expressed throughout primary neuronal cells in culture, possibly playing a developmental role in the central nervous system.

The Werner syndrome protein: an update

Progeria and progeroid syndromes are characterized by the earlier onset of complex senescent phenotypes. WRN was originally identified as a gene responsible for Werner syndrome (WS; "Progeria of Adults"). The WRN gene product has RecQ-type helicase domains in the central region of the protein. Subsequent studies also revealed that the WRN protein displays exonuclease activity and acts as a transcriptional activation factor. These biochemical studies, combined with cell biological studies, suggested that this protein is likely to be involved in the response to DNA damage during replication, as well as recombination and transcription processes. However, the precise molecular mechanisms by which mutations in WRN cause the WS phenotype remain unknown. Recent progress in the understanding of the WRN protein and its implication in the normal aging process are discussed.